stocks
Pfizer Reports Strong Q2 Earnings on Robust Sales of Cancer and Heart Drugs
The Pfizer Q2 earnings report has shown strong financial performance, largely driven by robust sales in cancer and heart disease drugs.
MarketAlleys Desk · · 2 min read